SciSparc (NASDAQ:SPRC) Trading 9.4% Higher – Time to Buy?

SciSparc Ltd. (NASDAQ:SPRC) shares were up 9.4% during trading on Thursday . The company traded as high as $5.40 and last traded at $5.36. Approximately 42,523 shares traded hands during trading, a decline of 1% from the average session volume of 43,100 shares. The stock had previously closed at $4.90.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of SciSparc in a report on Tuesday, May 26th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, SciSparc has an average rating of “Sell”.

SciSparc Trading Up 9.4%

The firm’s fifty day moving average is $6.53 and its two-hundred day moving average is $6.56.

SciSparc (NASDAQ:SPRC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported ($31.60) EPS for the quarter. The business had revenue of $0.20 million for the quarter.

About SciSparc

SciSparc AG is a clinical?stage medical technology company focused on the development and commercialization of extracorporeal shock wave–based neuromodulation devices. Founded in 2016 and headquartered in Switzerland, the company applies proprietary low?intensity shock wave technology to noninvasively stimulate neural tissue. SciSparc completed its initial public offering on the NASDAQ in 2021 under the ticker SPRC, securing funding to advance its clinical pipeline.

The company’s lead product, the TR100 system, delivers transcranial shock wave stimulation (tSWS) designed to target areas of the brain associated with motor control and cognitive function.